Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Ziektelast RS-virus verschilt sterk per land
jan 2025 | Vaccinatie, Virale infecties